Immunovant, Inc. (IMVT)
32.84
-0.46
(-1.38%)
USD |
NASDAQ |
Jun 01, 16:00
32.84
0.00 (0.00%)
After-Hours: 20:00
Immunovant EPS Diluted (Quarterly) : -0.7258 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Roivant Sciences Ltd. | 0.373 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Summit Therapeutics, Inc. | -0.2443 |
| Protagonist Therapeutics, Inc. | 0.0537 |
| UroGen Pharma Ltd. | -0.4698 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -147.86M |
| Total Expenses (Quarterly) | 147.86M |
| Enterprise Value | 5.935B |
| Earnings Yield | -8.43% |
| Normalized Earnings Yield | -8.434 |